Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04062123 · ClinicalTrials.gov registry record · Phase 1

Memory & Conditioning Under Anesthesia

A Phase 1 study, sponsored by Keith M Vogt.

Completed
Registry status
Phase 1
Development phase
92
Enrollment target

NCT04062123 is a Phase 1 study that has completed, run by Keith M Vogt. The registered enrollment target is 92 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04062123, a Phase 1 study, has completed, sponsored by Keith M Vogt.

COMPLETED
Registry status
Phase 1
Development phase
92 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of pain on long-term memory and conditioned physiologic responses in the presence and absence of distinct intravenous anesthetics. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena The study will occur over 5 visits and involves no long-term follow up.

Interventions

  • DRUG Placebo
  • DRUG Dexmedetomidine
  • DRUG Propofol
  • DEVICE Peripheral Nerve Stimulation
  • DRUG Fentanyl

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2020-07-30
Est. Completion 2024-04-22
Phase Phase 1

Sponsor

Keith M Vogt

7 total trials

What the Registry Record Tells You About NCT04062123

The ClinicalTrials.gov registry entry for NCT04062123 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Keith M Vogt, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.

NCT04062123 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04062123 about?

NCT04062123 is a clinical study titled "Memory & Conditioning Under Anesthesia". The purpose of this study is to determine the effects of pain on long-term memory and conditioned physiologic responses in the presence and absence of distinct intravenous anesthetics. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena The study w...

What is the current status of trial NCT04062123?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 92 participants. The study started on 2020-07-30. Estimated completion is 2024-04-22.

What interventions are being tested in trial NCT04062123?

The interventions under investigation include: Placebo (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG), Peripheral Nerve Stimulation (DEVICE), Fentanyl (DRUG).

Who is sponsoring clinical trial NCT04062123?

This trial is sponsored by Keith M Vogt, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.